| INHALATION DRUG MANUFACTURING |
Jennifer Markarian
A connected MDI may encourage compliance and aid proper technique.
/ read more /
| SCALE UP |
Agnes Shanley
Continuous manufacturing may offer huge opportunities but will not be right for every facility.
/ read more /
| PEER-REVIEWED RESEARCH |
Orlando López
Protecting the integrity of raw data is crucial to regulatory compliance and to proving that manufacturing and quality operations are being run and managed properly. / read more /
| GOOD LABORATORY PRACTICES |
Agnes Shanley
Quality and compliance depend on the right approaches to training, standard operating procedures, and validation. More tools are available to help ensure success. / read more /
| ANALYTICS |
Ioscani Jiménez del Val
Close collaboration between academic and industrial groups is vital to ensuring glycosylation models are fit for deployment.
/ read more /
| SUPPLY CHAIN |
Felicity Thomas
Proactive approaches that consider long-term supply chain security compliance are recommended to ensure companies stay on the right track. / read more /
Felicity Thomas
With an increased focus on the supply chain security of non-cGMP intermediates, companies need to re-emphasize upstream manufacturing. / read more /
| EDITOR'S COMMENT |
Felicity Thomas
Big Pharma is partnering with Alphabet company, Verily, to modernize clinical trials and accelerate time-to-market for drugs. / read more /
| EUROPEAN REGULATORY WATCH |
Sean Milmo
The current fragmented regulatory approach to cannabis medicines across Europe is challenging to harmonize. / read more /
| ASK THE EXPERT |
Susan Schniepp
A good working relationship between sponsor and contractor will become invaluable when an OOS occurs. / read more /
|